During the corresponding time, Pelthos Therapeutics Inc sequentially revenue grew by 43.07 %. While revenue at the Pelthos Therapeutics Inc 's corporate clients
Pelthos Therapeutics Inc's Comment on Sales, Marketing and Customers
The Company serves patients using its product ZELSUVMI, focusing on payer channels including commercial, Medicaid, and Managed Medicaid. It offers co-pay cards and coupons for eligible commercially insured patients. In December 2025, the Company entered its first commercial agreement with a major Pharmacy Benefit Manager (PBM) through a Group Purchasing Organization that works with manufacturers on behalf of one of the largest PBMs in the U.S., managing prescription drug benefits for over 20 million covered lives. The Company sources raw materials from third-party suppliers and utilizes third-party logistics vendors for transportation within its supply chain. Manufacturing is conducted at the Company's primary facility in North Carolina. The active pharmaceutical ingredient (API) is shipped to a third-party contract manufacturing organization (CMO) for conversion into the finished product, which is then distributed by a third-party logistics provider.
Pelthos Therapeutics Inc’s Comment on Sales, Marketing and Customers
The Company serves patients using its product ZELSUVMI, focusing on payer channels including commercial, Medicaid, and Managed Medicaid. It offers co-pay cards and coupons for eligible commercially insured patients. In December 2025, the Company entered its first commercial agreement with a major Pharmacy Benefit Manager (PBM) through a Group Purchasing Organization that works with manufacturers on behalf of one of the largest PBMs in the U.S., managing prescription drug benefits for over 20 million covered lives. The Company sources raw materials from third-party suppliers and utilizes third-party logistics vendors for transportation within its supply chain. Manufacturing is conducted at the Company's primary facility in North Carolina. The active pharmaceutical ingredient (API) is shipped to a third-party contract manufacturing organization (CMO) for conversion into the finished product, which is then distributed by a third-party logistics provider.
Sources:
Pelthos Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Pelthos Therapeutics Inc’s corporate clients.
For your research, we’ve provided 9 tables on Pelthos Therapeutics Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
68.35 %